Despite Zoetis' underperformance relative to the broader market over the past year, Wall Street analysts maintain a bullish ...

Worse still, if you'd only held Zoetis stock for the past one, or three, or five years, you would have lost money. Zoetis ...

Zoetis Inc. (NYSE:ZTS) is one of the best defensive stocks to invest in according to analysts. On July 10, Bank of America ...

Zoetis (NYSE:ZTS) added ~7% in the premarket on Tuesday after the animal health company exceeded Street forecasts with its Q2 ...

Zoetis stock reversed Tuesday, sinking into the red, despite beating second-quarter expectations as Librela sales continued ...

Zoetis raised annual forecast and beat second-quarter estimates on Tuesday, driven by strong demand for its medicines and ...

Meanwhile, the company has an impeccable dividend program. The company has increased its payouts by 502% over the past decade ...

Shares of Zoetis Inc. ZTS slipped 1.46% to $148.81 Wednesday, on what proved to be an all-around grim trading session for the ...

Shares of Zoetis Inc. ZTS rallied 1.09% to $147.38 Friday, on what proved to be an all-around dismal trading session for the ...

Zoetis's leadership, scale, and innovation position it well against new competitors. Click here to read more about ZTS stock and why it is a Buy.

Zoetis, a leading animal health company, has shown impressive growth with a 17.55% CAGR since its IPO. Read why I rate ZTS stock a Buy now.

Breed Explorer offers veterinarian-approved, science-backed insights to help current and prospective pet owners make informed ...